SE8903914D0 - Oral composition for the treatment of inflammatory bowel diseases - Google Patents

Oral composition for the treatment of inflammatory bowel diseases

Info

Publication number
SE8903914D0
SE8903914D0 SE8903914A SE8903914A SE8903914D0 SE 8903914 D0 SE8903914 D0 SE 8903914D0 SE 8903914 A SE8903914 A SE 8903914A SE 8903914 A SE8903914 A SE 8903914A SE 8903914 D0 SE8903914 D0 SE 8903914D0
Authority
SE
Sweden
Prior art keywords
treatment
inflammatory bowel
oral composition
bowel diseases
crohn
Prior art date
Application number
SE8903914A
Other languages
English (en)
Swedish (sv)
Inventor
Jan Ulmius
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8903914(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE8903914A priority Critical patent/SE8903914D0/xx
Publication of SE8903914D0 publication Critical patent/SE8903914D0/xx
Priority to NZ235807A priority patent/NZ235807A/xx
Priority to ZA908777A priority patent/ZA908777B/xx
Priority to TW079109396A priority patent/TW250435B/zh
Priority to SA90110123A priority patent/SA90110123B1/ar
Priority to SI9012150A priority patent/SI9012150A/sl
Priority to YU215090A priority patent/YU48583B/sh
Priority to DK91900414.3T priority patent/DK0502092T3/da
Priority to HU9201700A priority patent/HUT60630A/hu
Priority to SU5052239A priority patent/RU2134104C1/ru
Priority to CA002071518A priority patent/CA2071518C/en
Priority to DE69021214T priority patent/DE69021214T2/de
Priority to UA94051483A priority patent/UA37196C2/uk
Priority to SG1996004385A priority patent/SG54210A1/en
Priority to AT91900414T priority patent/ATE125445T1/de
Priority to ES91900414T priority patent/ES2074698T3/es
Priority to AU77864/91A priority patent/AU643021B2/en
Priority to KR1019920701202A priority patent/KR0179042B1/ko
Priority to JP50070991A priority patent/JP3145111B2/ja
Priority to DE199191900414T priority patent/DE502092T1/de
Priority to HU9201700A priority patent/HU216836B/hu
Priority to US09/159,301 priority patent/US6423340B1/en
Priority to EP91900414A priority patent/EP0502092B1/en
Priority to PCT/SE1990/000738 priority patent/WO1991007172A1/en
Priority to IE417090A priority patent/IE74854B1/en
Priority to EG69190A priority patent/EG19642A/xx
Priority to PL90287844A priority patent/PL166506B1/pl
Priority to IL9641590A priority patent/IL96415A/en
Priority to IS3644A priority patent/IS1858B/is
Priority to MYPI90002053A priority patent/MY104535A/en
Priority to PT95946A priority patent/PT95946A/pt
Priority to NO922004A priority patent/NO304010B1/no
Priority to FI922325A priority patent/FI104949B/fi
Priority to HRP-2150/90A priority patent/HRP920632B1/xx
Priority to LVP-93-1026A priority patent/LV10183B/en
Priority to LTIP1751A priority patent/LT3696B/lt
Priority to US08/240,078 priority patent/US5643602A/en
Priority to GR950402797T priority patent/GR3017691T3/el
Priority to HK51897A priority patent/HK51897A/xx
Priority to FI991893A priority patent/FI19991893A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
SE8903914A 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases SE8903914D0 (sv)

Priority Applications (40)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases
NZ235807A NZ235807A (en) 1989-11-22 1990-10-24 Controlled release pellet formulation (core coated with or comprising a glucocorticosteroid, and a polymeric outer coating); capsules containing pellets; and use in treating bowel disease
ZA908777A ZA908777B (en) 1989-11-22 1990-11-01 Oral composition for the treatment of inflammatory bowel diseases
TW079109396A TW250435B (ar) 1989-11-22 1990-11-07
SA90110123A SA90110123B1 (ar) 1989-11-22 1990-11-07 تركيبات فموية لعلاج أمراض الأحشاء
SI9012150A SI9012150A (sl) 1989-11-22 1990-11-13 Oralni pripravek za zdravljenje vnetnih črevesnih bolezni
YU215090A YU48583B (sh) 1989-11-22 1990-11-13 Postupak za pripremanje formulacije u obliku pilule za oralno davanje
EP91900414A EP0502092B1 (en) 1989-11-22 1990-11-15 Oral composition for the treatment of inflammatory bowel diseases
PCT/SE1990/000738 WO1991007172A1 (en) 1989-11-22 1990-11-15 Oral composition for the treatment of inflammatory bowel diseases
KR1019920701202A KR0179042B1 (ko) 1989-11-22 1990-11-15 염증성 장 질환 치료용 경구 조성물
AU77864/91A AU643021B2 (en) 1989-11-22 1990-11-15 Oral composition for the treatment of inflammatory bowel diseases
SU5052239A RU2134104C1 (ru) 1989-11-22 1990-11-15 Пероральная композиция для лечения воспалительных заболеваний кишечного тракта
CA002071518A CA2071518C (en) 1989-11-22 1990-11-15 Oral composition for the treatment of inflammatory bowel diseases
DE69021214T DE69021214T2 (de) 1989-11-22 1990-11-15 Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
UA94051483A UA37196C2 (uk) 1989-11-22 1990-11-15 Лікарська форма для перорального введення для лікування запальних хвороб кишкового тракту
SG1996004385A SG54210A1 (en) 1989-11-22 1990-11-15 Oral composition for the treatment of bowel inflammatory bowel diseases
AT91900414T ATE125445T1 (de) 1989-11-22 1990-11-15 Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
ES91900414T ES2074698T3 (es) 1989-11-22 1990-11-15 Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
HU9201700A HUT60630A (en) 1989-11-22 1990-11-15 Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
DK91900414.3T DK0502092T3 (da) 1989-11-22 1990-11-15 Oralt præparat til behandling af inflammatoriske tarmsygdomme
JP50070991A JP3145111B2 (ja) 1989-11-22 1990-11-15 炎症性腸疾患処置用経口組成物
DE199191900414T DE502092T1 (de) 1989-11-22 1990-11-15 Orale zusammensetzung fuer die behandlung intestinaler entzuendlicher krankheiten.
HU9201700A HU216836B (hu) 1989-11-22 1990-11-15 Eljárás gyulladásos jellegű bélbetegségek kezelésére alkalmas, budezonidot tartalmazó, perorális gyógyszerkészítmények előállítására
US09/159,301 US6423340B1 (en) 1989-11-22 1990-11-15 Method for the treatment of inflammatory bowel diseases
IL9641590A IL96415A (en) 1989-11-22 1990-11-20 Oral preparations for the treatment of delectable bowel diseases
EG69190A EG19642A (en) 1989-11-22 1990-11-20 A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
IE417090A IE74854B1 (en) 1989-11-22 1990-11-20 Oral composition for the treatment of inflammatory bowel diseases
PL90287844A PL166506B1 (pl) 1989-11-22 1990-11-20 Sposób wytwarzania formy peletkowej pozwalajacej na uwalnianie sie glikokortykosteroidu PL PL PL PL PL PL PL PL
IS3644A IS1858B (is) 1989-11-22 1990-11-21 Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
MYPI90002053A MY104535A (en) 1989-11-22 1990-11-21 Oral composition for the treatment of inflammatory bowel diseases.
PT95946A PT95946A (pt) 1989-11-22 1990-11-21 Processo para a prparacao de composicoes farmaceuticas de libertacao controlada contendo glucocorticosteroides utilizadas no ttratamento de doencas intestinais inflamatorias
NO922004A NO304010B1 (no) 1989-11-22 1992-05-21 FremgangsmÕte for fremstilling av en pelletformulering for bruk i behandlingen av inflammatoriske tarmsykdommer
FI922325A FI104949B (fi) 1989-11-22 1992-05-21 Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi
HRP-2150/90A HRP920632B1 (en) 1989-11-22 1992-09-30 Oral composition for the treatment of inflammatory bowel deseases
LVP-93-1026A LV10183B (en) 1989-11-22 1993-08-10 Oral composition for the treatment of inflammatory bowel diseases
LTIP1751A LT3696B (en) 1989-11-22 1993-12-31 Oral composition for the treatment of inflammatory bowel diseases
US08/240,078 US5643602A (en) 1989-11-22 1994-05-09 Oral composition for the treatment of inflammatory bowel disease
GR950402797T GR3017691T3 (en) 1989-11-22 1995-10-11 Oral composition for the treatment of inflammatory bowel diseases.
HK51897A HK51897A (en) 1989-11-22 1997-04-24 Oral composition for the treatment of inflammatory bowel diseases
FI991893A FI19991893A (fi) 1989-11-22 1999-09-06 Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
SE8903914D0 true SE8903914D0 (sv) 1989-11-22

Family

ID=20377544

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases

Country Status (36)

Country Link
US (1) US6423340B1 (ar)
EP (1) EP0502092B1 (ar)
JP (1) JP3145111B2 (ar)
KR (1) KR0179042B1 (ar)
AT (1) ATE125445T1 (ar)
AU (1) AU643021B2 (ar)
CA (1) CA2071518C (ar)
DE (1) DE69021214T2 (ar)
DK (1) DK0502092T3 (ar)
EG (1) EG19642A (ar)
ES (1) ES2074698T3 (ar)
FI (2) FI104949B (ar)
GR (1) GR3017691T3 (ar)
HK (1) HK51897A (ar)
HR (1) HRP920632B1 (ar)
HU (2) HUT60630A (ar)
IE (1) IE74854B1 (ar)
IL (1) IL96415A (ar)
IS (1) IS1858B (ar)
LT (1) LT3696B (ar)
LV (1) LV10183B (ar)
MY (1) MY104535A (ar)
NO (1) NO304010B1 (ar)
NZ (1) NZ235807A (ar)
PL (1) PL166506B1 (ar)
PT (1) PT95946A (ar)
RU (1) RU2134104C1 (ar)
SA (1) SA90110123B1 (ar)
SE (1) SE8903914D0 (ar)
SG (1) SG54210A1 (ar)
SI (1) SI9012150A (ar)
TW (1) TW250435B (ar)
UA (1) UA37196C2 (ar)
WO (1) WO1991007172A1 (ar)
YU (1) YU48583B (ar)
ZA (1) ZA908777B (ar)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
SK87295A3 (en) * 1993-01-08 1996-04-03 Astra Ab Novel colon or ileum-specific steroid derivatives
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
KR20000053327A (ko) * 1996-11-15 2000-08-25 데이비드 엠 모이어 결장내 운반에 사용되는 약학적 제형
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
AU2002254205B2 (en) * 2001-03-15 2007-05-10 Enteron Pharmaceuticals, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
US20060211668A1 (en) * 2003-09-15 2006-09-21 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
US20070243184A1 (en) * 2005-11-08 2007-10-18 Steven Fischkoff Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
EP2334178A4 (en) * 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
CA2826662A1 (en) * 2011-02-04 2012-08-09 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
MD480Z5 (ro) * 2011-07-07 2012-09-30 Эльвира АНДОН Metodă de tratament al colitei ulceroase nespecifice acute
HUE036187T2 (hu) 2012-04-30 2018-06-28 Tillotts Pharma Ag Késleltetett leadású gyógyszerkészítmény
UA117260C2 (uk) 2013-10-29 2018-07-10 Тиллоттс Фарма АГ Лікарський препарат з відстроченим вивільненням
WO2017042835A1 (en) * 2015-09-11 2017-03-16 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
ES2874546T3 (es) * 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
EP3413877B1 (en) * 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (ar) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
IL96415A0 (en) 1991-08-16
NO304010B1 (no) 1998-10-12
JP3145111B2 (ja) 2001-03-12
PL166506B1 (pl) 1995-05-31
FI104949B (fi) 2000-05-15
WO1991007172A1 (en) 1991-05-30
YU215090A (sr) 1996-01-09
HRP920632B1 (en) 1999-10-31
LV10183A (lv) 1994-10-20
IE904170A1 (en) 1991-05-22
IS1858B (is) 2003-03-27
FI19991893A (fi) 1999-09-06
IL96415A (en) 1995-11-27
SA90110123B1 (ar) 1999-06-06
IS3644A7 (is) 1991-05-23
RU2134104C1 (ru) 1999-08-10
PL287844A1 (en) 1991-12-02
IE74854B1 (en) 1997-08-13
JPH05501705A (ja) 1993-04-02
AU7786491A (en) 1991-06-13
US6423340B1 (en) 2002-07-23
PT95946A (pt) 1991-09-13
NO922004D0 (no) 1992-05-21
NO922004L (no) 1992-05-21
CA2071518C (en) 2002-11-12
KR920703025A (ko) 1992-12-17
HK51897A (en) 1997-05-02
YU48583B (sh) 1998-12-23
MY104535A (en) 1994-04-30
EG19642A (en) 1995-08-30
EP0502092B1 (en) 1995-07-26
LV10183B (en) 1995-08-20
ZA908777B (en) 1991-07-31
DE69021214T2 (de) 1996-01-04
SI9012150A (sl) 1998-08-31
KR0179042B1 (ko) 1999-03-20
DK0502092T3 (da) 1995-12-27
HRP920632A2 (en) 1995-04-30
SG54210A1 (en) 1998-11-16
DE69021214D1 (de) 1995-08-31
LTIP1751A (en) 1995-07-25
EP0502092A1 (en) 1992-09-09
NZ235807A (en) 1993-02-25
FI922325A (fi) 1992-05-21
HU9201700D0 (en) 1992-08-28
GR3017691T3 (en) 1996-01-31
LT3696B (en) 1996-02-26
ATE125445T1 (de) 1995-08-15
CA2071518A1 (en) 1991-05-23
HU216836B (hu) 1999-09-28
TW250435B (ar) 1995-07-01
ES2074698T3 (es) 1995-09-16
UA37196C2 (uk) 2001-05-15
AU643021B2 (en) 1993-11-04
HUT60630A (en) 1992-10-28
FI922325A0 (fi) 1992-05-21

Similar Documents

Publication Publication Date Title
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
NO943901D0 (no) Fremgangsmåter og preparater for behandling av sykdommer med interferon samtidig som bivirkninger reduseres
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
DE69905368D1 (en) Oxydiertes thymosin beta 4
EP0151989A3 (en) Means for the treatment of cardiac diseases
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
FR2784897B1 (fr) Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
CA2091134A1 (en) Therapeutic agent for threatened abortion
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
RU99107944A (ru) Лечебное средство прямого антикоагулянтного и фибринолитического действия
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.